Article Figures & Data
Figures
- Figure 1.
Stage of change tool in MLIT used to guide clinician to appropriate stage-based intervention.
- Figure 2.
Initial “contemplation” content screen.
- Figure 3.
Appropriate stage-based interventions for clinicians to use with patients in contemplation stage.
- Figure 4.
Physician prompts for addressing “decisional balance” with patient in contemplation stage.
- Figure 5.
Physician prompts for “supporting self-efficacy” of patients.
- Figure 6.
National and local resources listed to prompt physicians to arrange follow-up with patients.
Tables
- Table 1. Changes in Physician Comfort Levels with Smoking Cessation Counseling and Self-Reported Counseling Behaviors Before and After the Intervention (n = 17)
Before Intervention After Intervention P Comfort/self-efficacy subscale (mean score)* Effective counseling of patients 4.3 5.0 .006 Comfort following patients who are attempting to quit 4.9 5.6 .04 Physician smoking cessation counseling behavior subscale (mean score)† Summed 5 As behavior 11.0 11.8 .03 Advising smokers to quit 2.5 2.7 .05 Assisting smokers with quitting 2.0 2.2 .09 Physician performance, % (n) Use of stage-specific interventions 71 (12) 100 (17) Unavailable Use of motivational interviewing 82 (14) 94 (16) .48 Use of Public Health Service guidelines 12 (2) 29 (5) .39 Use of nicotine lozenges 18 (3) 47 (8) .07 Physician smoking cessation knowledge subscale Overall knowledge (%) 75.2 76.9 NS Smoking pharmacologic treatment knowledge 50 64.7 .05 Clinicians Completing Study With Valid Log Files (n = 14) Total sessions with MLIT tool 71 Average sessions per user 5 (1–29) Total pages accessed 275 (1–86) Average pages per session 20 (1–87) Total time accessed (min) 289 (1–118) Average session length (min) 21 (1–29) Data provide as n (range).
Specific smoking content accessed (n = 223) Stages of change 64% Motivational interviewing 4% Smoking dependency assessment (Fagerstrom) 9% Pharmacotherapy 14% Smoking cessation resources 9% Stages of change accessed (n = 143) Precontemplation 18% Contemplation 19% Preparation 19% Action 9% Maintenance 11% Relapse 4% Unspecified 20% Pharmacotherapy Accessed (n = 30) First-line smoking cessation drugs 63% Second-line smoking cessation drugs 37%
